Results 21 to 30 of about 2,924 (209)

Association of Dietary Advanced Glycation End Products with Metabolic Syndrome in Young Mexican Adults

Medicines, 2018
Background: Consumption of dietary advanced glycation end products is linked to metabolic syndrome. The objective was to describe the association between dietary advanced glycation end products intake and metabolic syndrome in young Mexican adults ...
Kenny Mendoza-Herrera, Celia Aradillas-García, Miguel A. Mejía-Diaz, Jorge A. Alegría-Torres, Ma. Eugenia Garay-Sevilla, Claudia Luevano-Contreras   +5 more
doaj   +1 more source

Advanced Glycation End Products and Receptor for Advanced Glycation End Products in AA Amyloidosis

The American Journal of Pathology, 2003
Advanced glycation end products (AGEs) may be involved in either amyloidogenesis or complications related to amyloid. We hypothesized that AGEs may influence the pathogenesis of AA amyloidosis, and investigated the spatial and temporal relationship between AGEs, carboxy methyl lysine (CML), the AGE receptor (RAGE), and AA amyloid in humans and mice ...
Christoph, Röcken, Rosemarie, Kientsch-Engel, Sophie, Mansfeld, Barbara, Stix, Kay, Stubenrauch, Bernd, Weigle, Frank, Bühling, Mona, Schwan, Wolfgang, Saeger   +8 more
openaire   +3 more sources

Advanced glycation end products and diabetic retinopathy [PDF]

Journal of Ocular Biology, Diseases, and Informatics, 2012
Studies have established hyperglycemia as the most important factor in the progress of vascular complications. Formation of advanced glycation end products (AGEs) correlates with glycemic control. The AGE hypothesis proposes that hyperglycemia contributes to the pathogenesis of diabetic complications including retinopathy.
Yashodhara, Sharma, Sandeep, Saxena, Arvind, Mishra, Anita, Saxena, Shankar Madhav, Natu   +4 more
openaire   +2 more sources

Antiglycation potential of commercial available extracts of two Indian medicinal plants: Pterocarpus marsupium and Artocarpus lakoocha using advanced glycation end products (AGE) competitive fluorescence assay

Cogent Food & Agriculture, 2021
Glycation is a non-enzymatic biochemical reaction between reducing sugars and amino acids, causing the crosslinking and rearrangement of glycated proteins, leading to irreversible formation of Advanced Glycation End products (AGEs).
Alpana Pande, Lakshmi Mundkur, Anurag Pande, Sarang Bani, Muhammed Majeed   +4 more
doaj   +1 more source

Magnolol ameliorates the accumulation of reactive oxidative stress and inflammation in diabetic periodontitis

Journal of the Formosan Medical Association, 2021
Background/Purpose: Periodontal disease and diabetes mellitus (DM) are both chronic inflammatory and highly prevalent diseases. A large amount of evidence suggested that the accumulation of oxidative stress plays a significant role in the deterioration ...
Chia-Ming Liu, Szu-Han Chen, Yi-Wen Liao, Chuan-Hang Yu, Cheng-Chia Yu, Pei-Ling Hsieh   +5 more
doaj   +1 more source

Advanced Glycation End Products and Diabetic Complications [PDF]

The Korean Journal of Physiology & Pharmacology, 2014
During long standing hyperglycaemic state in diabetes mellitus, glucose forms covalent adducts with the plasma proteins through a non-enzymatic process known as glycation. Protein glycation and formation of advanced glycation end products (AGEs) play an important role in the pathogenesis of diabetic complications like retinopathy, nephropathy ...
Singh, Varun Parkash, Bali, Anjana, Singh, Nirmal, Jaggi, Amteshwar Singh   +3 more
openaire   +2 more sources

Clinical Value of High Mobility Group Box 1 and the Receptor for Advanced Glycation End-products in Head and Neck Cancer: A Systematic Review

International Archives of Otorhinolaryngology, 2016
Introduction High mobility group box 1 is a versatile protein involved in gene transcription, extracellular signaling, and response to inflammation. Extracellularly, high mobility group box 1 binds to several receptors, notably the receptor for advanced ...
Austin Nguyen, Sheila Bhavsar, Erinn Riley, Gabriel Caponetti, Devendra Agrawal   +4 more
doaj   +1 more source

The Role of Advanced Glycation End Products on Dyslipidemia

Metabolites, 2023
Disorders of lipoprotein metabolism and glucose homeostasis are common consequences of insulin resistance and usually co-segregate in patients with metabolic syndrome and type 2 diabetes mellitus (DM).
Jelena Vekic, Sanja Vujcic, Biljana Bufan, Dragana Bojanin, Khamis Al-Hashmi, Khaild Al-Rasadi, Anca Pantea Stoian, Aleksandra Zeljkovic, Manfredi Rizzo   +8 more
doaj   +1 more source

Increased concentration of two different advanced glycation end-products detected by enzyme immunoassays with new monoclonal antibodies in sera of patients with rheumatoid arthritis

BMC Musculoskeletal Disorders, 2010
Background Levels of pentosidine (representative of advanced glycation end-products) in sera of patients with rheumatoid arthritis are increased when compared with sera of other diagnoses or healthy controls.
Vilím Vladimír, Šedová Liliana, Vytášek Richard   +2 more
doaj   +1 more source

Polymorphisms of the receptor for advanced glycation end products and glyoxalase I and long-term outcome in patients with breast cancer

Tumor Biology, 2017
Receptor for advanced glycation end products and glyoxalase I metabolizing advanced glycation end product precursors may play important role in the pathogenesis and progression of cancer.
Petra Tesarova, Tomas Zima, Ales A Kubena, Marta Kalousova   +3 more
doaj   +1 more source